Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Biliary Tract Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, China
Contact: Study coordinator (Lianxin Liu)
Contact: Principal Investigator (Lianxin Liu)

Study leads

Jason Wu
Study Chair
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma

Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma

Unresectable Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Zhengzhou, China

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Advanced Biliary Tract Carcinoma · Advanced Colorectal Carcinoma · Advanced Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Chicago, United States

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Advanced Malignant Solid Neoplasm · Advanced Biliary Tract Carcinoma · Advanced Esophageal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Portland, United States